Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo

This publication has 14 references indexed in Scilit:

• Position statement: global neuraminidase inhibitor susceptibility network
  Antiviral Research, 2001
• Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with Oseltamivir
  The Journal of Infectious Diseases, 2001
• Management of Influenza
  Clinical Drug Investigation, 2000
• Resistance of influenza viruses to neuraminidase inhibitors — a review
  Antiviral Research, 2000
• 80 Characterization of an influenza A virus variant selected in vitro in the presence of the neuraminidase inhibitor, GS4071 : ZM Wang, CY Tai, DB Mendel. Gilead Sciences, Foster City, California
  Antiviral Research, 2000
• 82 Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor RWJ-270201 : S. Bantia1, S. Ananth1, L. Horn1, C. Parker1, U. Gulati2, P. Chand1, Y. Babu1, G. Air2 1BioCryst Pharmaceuticals, Inc., Birmingham, AL, U.S.A., 2University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73190
  Antiviral Research, 2000
• 79 Virological assessment in vitro and in vivo of an influenza H1N1 virus with a H274Y mutation in the neuraminidase gene: Carr J, Ives J, Roberts N, Kelly L∗, Lambkin R∗, Oxford J∗, Tai CY+, Mendel D+ Hayden F$ Roche Discovery Welwyn, Welwyn Garden City, UK. ∗Retroscreen Ltd. www.Retroscreen.com +Gilead Sciences, Foster City, CA $ University of Virginia, Charlottesville, VA
  Antiviral Research, 2000
• Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza
  JAMA, 2000
• Influenza virus neuraminidase: Structure, antibodies, and inhibitors
  Protein Science, 1994
• Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d-N-acetylneuraminate) substrate
  Analytical Biochemistry, 1979